GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $204,000 | -83.3% | 79,500 | -84.3% | 0.00% | -100.0% |
| Q2 2022 | $1,222,000 | +19.9% | 504,873 | +352.5% | 0.00% | 0.0% |
| Q2 2021 | $1,019,000 | +2.6% | 111,572 | -55.7% | 0.00% | 0.0% |
| Q4 2020 | $993,000 | +11.4% | 251,982 | -25.1% | 0.00% | 0.0% |
| Q3 2020 | $891,000 | -3.2% | 336,400 | +142.8% | 0.00% | 0.0% |
| Q2 2020 | $920,000 | +219.4% | 138,573 | +179.9% | 0.00% | – |
| Q1 2020 | $288,000 | – | 49,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
| Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
| Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
| Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
| Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
| Bleichroeder LP | 169,039 | $984,000 | 0.26% |
| Leap Investments LP | 14,400 | $84,000 | 0.12% |
| DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
| Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |